Researchers develop a dissolvable 3D-printed skin patch designed to improve treatment for localized skin cancer. Multiple outlets report the patch is being developed in Belfast by researchers at Queen’s University Belfast.
The patch uses microneedles to deliver medicines through the skin. One outlet says the microneedles can administer two anti-cancer drugs, while other coverage focuses more broadly on the patch’s aim to improve delivery and treatment outcomes for people with localized disease. Across reports, the patch is described as tiny and dissolvable, intended to reduce the need for more invasive delivery methods.
Coverage is largely consistent on the origin of the research, the dissolvable nature of the device, and its potential use in localized skin cancer. The main difference is the level of detail: some outlets mention drug delivery via microneedles and the prospect of using two anti-cancer drugs, while others describe the initiative at a higher level without specifying the number or type of drugs.
